Appropriate use of antiplatelet medications following transient ischemic attacks and stroke: a 9-year study from the Middle East
Background and purposeGuidelines recommend that patients with high-risk TIAs and minor strokes presenting within 1–3 days from onset should be offered dual antiplatelet therapy (DAPT). There are little data on real-world adherence to these recommendations. We evaluated the appropriateness of DAPT us...
Main Authors: | Hiba Naveed, Naveed Akhtar, Salman Al-Jerdi, Ryan Ty Uy, Sujatha Joseph, Deborah Morgan, Blessy Babu, Shobana Shanthi, Ashfaq Shuaib |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-11-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1269292/full |
Similar Items
-
Dual Antiplatelet Therapy: A Concise Review for Clinicians
by: Hafeez Ul Hassan Virk, et al.
Published: (2023-07-01) -
Thirty-Days versus Longer Duration of Dual Antiplatelet Treatment after Percutaneous Coronary Interventions with Newer Drug-Eluting Stents: A Systematic Review and Meta-Analysis
by: Grigorios Tsigkas, et al.
Published: (2023-02-01) -
Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
by: Leonardo De Luca, et al.
Published: (2021-04-01) -
Antiplatelet Therapy in Acute Coronary Syndrome
by: I. M. Kuzmina, et al.
Published: (2022-01-01) -
Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
by: Ma Y, et al.
Published: (2018-05-01)